LTR Pharma is pleased to announce it has entered into an access agreement with Men’s Health Downunder (MHDU) to facilitate access to SPONTAN® through the Therapeutic Goods Administration’s (TGA) Special Access Scheme.
MHDU is a specialised men’s health provider operating a multidisciplinary network of healthcare professionals. The partnership has already achieved its first milestone, with MHDU dispensing SPONTAN® to its first patient under the agreement.
The agreement leverages MHDU’s established network of specially trained pharmacists and comprehensive men’s health services across multiple locations in Australia. MHDU’s clinics currently service over 1,000 patients annually through specialist urological health support services.
The agreement provides LTR Pharma access to MHDU’s extensive referral network, including general practitioners, urologists, and sexual health clinics. This partnership aligns with the Company’s strategy to introduce SPONTAN through trusted healthcare providers while gathering valuable real-world patient data.
LTR Pharma Chairman, Lee Rodne said:
“The agreement with Men’s Health Downunder represents another significant milestone in SPONTAN’s commercialisation journey. By partnering with Australia’s largest men’s health pharmacy clinic, we continue to broaden access to SPONTAN while maintaining our commitment to patient care through qualified healthcare professionals.”